Skip to main content
Erschienen in: Japanese Journal of Radiology 5/2024

31.01.2024 | Original Article

Systematic training of LI-RADS CT v2018 improves interobserver agreements and performances in LR categorization for focal liver lesions

verfasst von: Te Ba, Hui Xu, Da-Wei Yang, Zhen-Chang Wang, Zhenghan Yang, A-Hong Ren

Erschienen in: Japanese Journal of Radiology | Ausgabe 5/2024

Einloggen, um Zugang zu erhalten

Abstract

Aim

To retrospectively explored whether systematic training in the use of Liver Imaging Reporting and Data System (LI-RADS) v2018 on computed tomography (CT) can improve the interobserver agreements and performances in LR categorization for focal liver lesions (FLLs) among different radiologists.

Materials and methods

A total of 18 visiting radiologists and the liver multiphase CT images of 70 hepatic observations in 63 patients at high risk of HCC were included in this study. The LI-RADS v2018 training procedure included three thematic lectures, with an interval of 1 month. After each seminar, the radiologists had 1 month to adopt the algorithm into their daily work. The interobserver agreements and performances in LR categorization for FLLs among the radiologists before and after training were compared.

Results

After training, the interobserver agreements in classifying the LR categories for all radiologists were significantly increased for most LR categories (P < 0.001), except for LR-1 (P = 0.053). After systematic training, the areas under the curve (AUCs) for LR categorization performance for all participants were significantly increased for most LR categories (P < 0.001), except for LR-1 (P = 0.062).

Conclusion

Systematic training in the use of the LI-RADS can improve the interobserver agreements and performances in LR categorization for FLLs among radiologists with different levels of experience.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Xiao J, Wang F, Wong NK, He J, Zhang R, Sun R, et al. Global liver disease burdens and research trends: analysis from a Chinese perspective. J Hepatol. 2019;71(1):212–21.CrossRefPubMed Xiao J, Wang F, Wong NK, He J, Zhang R, Sun R, et al. Global liver disease burdens and research trends: analysis from a Chinese perspective. J Hepatol. 2019;71(1):212–21.CrossRefPubMed
2.
Zurück zum Zitat Cao M, Li H, Sun D, Chen W. Cancer burden of major cancers in China: a need for sustainable actions. Cancer Commun (Lond). 2020;40(5):205–10.CrossRefPubMed Cao M, Li H, Sun D, Chen W. Cancer burden of major cancers in China: a need for sustainable actions. Cancer Commun (Lond). 2020;40(5):205–10.CrossRefPubMed
3.
Zurück zum Zitat Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358–80.CrossRefPubMed Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358–80.CrossRefPubMed
4.
Zurück zum Zitat Kim TH, Kim SY, Tang A, Lee JM. Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update. Clin Mol Hepatol. 2019;25(3):245–63.CrossRefPubMedPubMedCentral Kim TH, Kim SY, Tang A, Lee JM. Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update. Clin Mol Hepatol. 2019;25(3):245–63.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Huang J, Lok V, Ngai CH, Chu C, Patel HK, Thoguluva Chandraseka V, et al. Disease burden, risk factors, and recent trends of liver cancer: a global country-level analysis. Liver Cancer. 2021;10(4):330–45.CrossRefPubMedPubMedCentral Huang J, Lok V, Ngai CH, Chu C, Patel HK, Thoguluva Chandraseka V, et al. Disease burden, risk factors, and recent trends of liver cancer: a global country-level analysis. Liver Cancer. 2021;10(4):330–45.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Renzulli M, Brocchi S, Ierardi AM, Milandri M, Pettinari I, Lucidi V, et al. Imaging-based diagnosis of benign lesions and pseudolesions in the cirrhotic liver. Magn Reson Imaging. 2021;75:9–20.CrossRefPubMed Renzulli M, Brocchi S, Ierardi AM, Milandri M, Pettinari I, Lucidi V, et al. Imaging-based diagnosis of benign lesions and pseudolesions in the cirrhotic liver. Magn Reson Imaging. 2021;75:9–20.CrossRefPubMed
7.
Zurück zum Zitat Corwin MT, Lee AY, Fananapazir G, Loehfelm TW, Sarkar S, Sirlin CB. Nonstandardized terminology to describe focal liver lesions in patients at risk for hepatocellular carcinoma: implications regarding clinical communication. AJR Am J Roentgenol. 2018;210(1):85–90.CrossRefPubMed Corwin MT, Lee AY, Fananapazir G, Loehfelm TW, Sarkar S, Sirlin CB. Nonstandardized terminology to describe focal liver lesions in patients at risk for hepatocellular carcinoma: implications regarding clinical communication. AJR Am J Roentgenol. 2018;210(1):85–90.CrossRefPubMed
10.
Zurück zum Zitat Elsayes KM, Fowler KJ, Chernyak V, Elmohr MM, Kielar AZ, Hecht E, et al. User and system pitfalls in liver imaging with LI-RADS. J Magn Reson Imaging. 2019;50(6):1673–86.CrossRefPubMed Elsayes KM, Fowler KJ, Chernyak V, Elmohr MM, Kielar AZ, Hecht E, et al. User and system pitfalls in liver imaging with LI-RADS. J Magn Reson Imaging. 2019;50(6):1673–86.CrossRefPubMed
11.
Zurück zum Zitat Fowler KJ, Tang A, Santillan C, Bhargavan-Chatfield M, Heiken J, Jha RC, et al. Interreader reliability of LI-RADS version 2014 algorithm and imaging features for diagnosis of hepatocellular carcinoma: a large international multireader study. Radiology. 2018;286(1):173–85.CrossRefPubMed Fowler KJ, Tang A, Santillan C, Bhargavan-Chatfield M, Heiken J, Jha RC, et al. Interreader reliability of LI-RADS version 2014 algorithm and imaging features for diagnosis of hepatocellular carcinoma: a large international multireader study. Radiology. 2018;286(1):173–85.CrossRefPubMed
12.
Zurück zum Zitat Kang JH, Choi SH, Lee JS, Kim KW, Kim SY, Lee SS, et al. Inter-reader reliability of CT liver imaging reporting and data system according to imaging analysis methodology: a systematic review and meta-analysis. Eur Radiol. 2021;31(9):6856–67.CrossRefPubMed Kang JH, Choi SH, Lee JS, Kim KW, Kim SY, Lee SS, et al. Inter-reader reliability of CT liver imaging reporting and data system according to imaging analysis methodology: a systematic review and meta-analysis. Eur Radiol. 2021;31(9):6856–67.CrossRefPubMed
13.
Zurück zum Zitat Elmohr MM, Iaeger PI, Kielar AZ, Chernyak V, Rohren SA, Sirlin CB, et al. The dissemination of hepatocellular carcinoma diagnosis guidelines using the method of teaching the teachers. J Am Coll Radiol. 2020;17(11):1491–5.CrossRefPubMed Elmohr MM, Iaeger PI, Kielar AZ, Chernyak V, Rohren SA, Sirlin CB, et al. The dissemination of hepatocellular carcinoma diagnosis guidelines using the method of teaching the teachers. J Am Coll Radiol. 2020;17(11):1491–5.CrossRefPubMed
14.
Zurück zum Zitat Zhang N, Xu H, Ren AH, Zhang Q, Yang DW, Ba T, et al. Does training in LI-RADS version 2018 improve readers’ agreement with the expert consensus and inter-reader agreement in MRI interpretation? J Magn Reson Imaging. 2021;54(6):1922–34.CrossRefPubMed Zhang N, Xu H, Ren AH, Zhang Q, Yang DW, Ba T, et al. Does training in LI-RADS version 2018 improve readers’ agreement with the expert consensus and inter-reader agreement in MRI interpretation? J Magn Reson Imaging. 2021;54(6):1922–34.CrossRefPubMed
15.
Zurück zum Zitat Ren AH, Xu H, Yang DW, Zhang N, Ba T, Wang ZC, et al. Systematic training of liver imaging reporting and data system magnetic resonance imaging v2018 can improve the diagnosis of hepatocellular carcinoma for different radiologists. J Clin Transl Hepatol. 2021;9(4):537–44.PubMedPubMedCentral Ren AH, Xu H, Yang DW, Zhang N, Ba T, Wang ZC, et al. Systematic training of liver imaging reporting and data system magnetic resonance imaging v2018 can improve the diagnosis of hepatocellular carcinoma for different radiologists. J Clin Transl Hepatol. 2021;9(4):537–44.PubMedPubMedCentral
16.
Zurück zum Zitat Choi JY, Cho HC, Sun M, Kim HC, Sirlin CB. Indeterminate observations (liver imaging reporting and data system category 3) on MRI in the cirrhotic liver: fate and clinical implications. AJR Am J Roentgenol. 2013;201(5):993–1001.CrossRefPubMed Choi JY, Cho HC, Sun M, Kim HC, Sirlin CB. Indeterminate observations (liver imaging reporting and data system category 3) on MRI in the cirrhotic liver: fate and clinical implications. AJR Am J Roentgenol. 2013;201(5):993–1001.CrossRefPubMed
17.
Zurück zum Zitat Tanabe M, Kanki A, Wolfson T, Costa EA, Mamidipalli A, Ferreira MP, et al. Imaging outcomes of liver imaging reporting and data system version 2014 category 2, 3, and 4 observations detected at CT and MR imaging. Radiology. 2016;281(1):129–39.CrossRefPubMed Tanabe M, Kanki A, Wolfson T, Costa EA, Mamidipalli A, Ferreira MP, et al. Imaging outcomes of liver imaging reporting and data system version 2014 category 2, 3, and 4 observations detected at CT and MR imaging. Radiology. 2016;281(1):129–39.CrossRefPubMed
20.
Zurück zum Zitat Sevim S, Dicle O, Gezer NS, Barış MM, Altay C, Akın IB. How high is the inter-observer reproducibility in the LIRADS reporting system? Pol J Radiol. 2019;84:e464–9.CrossRefPubMedPubMedCentral Sevim S, Dicle O, Gezer NS, Barış MM, Altay C, Akın IB. How high is the inter-observer reproducibility in the LIRADS reporting system? Pol J Radiol. 2019;84:e464–9.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Kang JH, Choi SH, Lee JS, Park SH, Kim KW, Kim SY, et al. Interreader agreement of liver imaging reporting and data system on MRI: a systematic review and meta-analysis. J Magn Reson Imaging. 2020;52(3):795–804.CrossRefPubMed Kang JH, Choi SH, Lee JS, Park SH, Kim KW, Kim SY, et al. Interreader agreement of liver imaging reporting and data system on MRI: a systematic review and meta-analysis. J Magn Reson Imaging. 2020;52(3):795–804.CrossRefPubMed
22.
Zurück zum Zitat Kim YY, Kim MJ, Kim EH, Roh YH, An C. Hepatocellular carcinoma versus other hepatic malignancy in cirrhosis: performance of LI-RADS version 2018. Radiology. 2019;291(1):72–80.CrossRefPubMed Kim YY, Kim MJ, Kim EH, Roh YH, An C. Hepatocellular carcinoma versus other hepatic malignancy in cirrhosis: performance of LI-RADS version 2018. Radiology. 2019;291(1):72–80.CrossRefPubMed
23.
Zurück zum Zitat Bae JS, Lee JM, Jeon SK, Yoo J, Park SJ, Yoon JH, et al. LI-RADS tumor in vein at CT and hepatobiliary MRI. Radiology. 2022;302(1):107–15.CrossRefPubMed Bae JS, Lee JM, Jeon SK, Yoo J, Park SJ, Yoon JH, et al. LI-RADS tumor in vein at CT and hepatobiliary MRI. Radiology. 2022;302(1):107–15.CrossRefPubMed
24.
Zurück zum Zitat Toh MR, Wong EYT, Wong SH, Ng AWT, Loo LH, Chow PK, et al. Global epidemiology and genetics of hepatocellular carcinoma. Gastroenterology. 2023;164(5):766–82.CrossRefPubMed Toh MR, Wong EYT, Wong SH, Ng AWT, Loo LH, Chow PK, et al. Global epidemiology and genetics of hepatocellular carcinoma. Gastroenterology. 2023;164(5):766–82.CrossRefPubMed
26.
Zurück zum Zitat Ahn Y, Choi SH, Jang JK, Kim SY, Shim JH, Lee SS, et al. Impact of the liver imaging reporting and data system on research studies of diagnosing hepatocellular carcinoma using MRI. Korean J Radiol. 2023;23(5):529–38.CrossRef Ahn Y, Choi SH, Jang JK, Kim SY, Shim JH, Lee SS, et al. Impact of the liver imaging reporting and data system on research studies of diagnosing hepatocellular carcinoma using MRI. Korean J Radiol. 2023;23(5):529–38.CrossRef
Metadaten
Titel
Systematic training of LI-RADS CT v2018 improves interobserver agreements and performances in LR categorization for focal liver lesions
verfasst von
Te Ba
Hui Xu
Da-Wei Yang
Zhen-Chang Wang
Zhenghan Yang
A-Hong Ren
Publikationsdatum
31.01.2024
Verlag
Springer Nature Singapore
Erschienen in
Japanese Journal of Radiology / Ausgabe 5/2024
Print ISSN: 1867-1071
Elektronische ISSN: 1867-108X
DOI
https://doi.org/10.1007/s11604-023-01523-x

Weitere Artikel der Ausgabe 5/2024

Japanese Journal of Radiology 5/2024 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.